AI-generated summary
The authors pooled 9 randomized controlled trials including 325 fibromyalgia patients to assess low-level laser therapy. They report that LLLT was associated with greater improvement than placebo laser in several outcomes, including impact scores, pain and fatigue, though the added value over exercise alone was not shown. Limitations included low-to-middle methodological quality and heterogeneity across studies.
- Participants
- 325
- Studies included
- 9
- Who or what was studied
- Patients with fibromyalgia
- Limits stated in the abstract
- The authors note low-to-middle methodological quality of the included studies, limited blinding, a 20% loss to follow-up in one study, and heterogeneity in laser types and protocols.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Fibromyalgia, Meta-analysis, Laser, Systematic review, Depression, Light-emitting diode, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.